DUBLIN--(BUSINESS WIRE)--The 'Technological Advances in Regenerative Medicine' report has been added to ResearchAndMarkets.com's offering.

都柏林--（商业新闻短讯）--“再生医学技术进步”报告已添加到ResearchAndMarkets.com的产品中。

This report covers incremental technological improvements and the new platforms that stakeholders have designed for stem cell therapy developments in induced pluripotent stem cells, mesenchymal stem cells, hematopoietic stem cells, and human embryonic stem cells.

本报告涵盖了增量技术改进以及利益相关者为诱导多能干细胞，间充质干细胞，造血干细胞和人类胚胎干细胞的干细胞治疗开发设计的新平台。

Regenerative medicine has evolved significantly and today includes several commercialized stem cell therapies. Researchers have made notable technological developments in stem cell therapies to overcome challenges related to large-scale manufacturing and cell quality. Stem cell research is more focused on induced pluripotent stem cells than on mesenchymal and hematopoietic stem cells, a transition caused by the fast-paced developments in iPSC research.

再生医学已经取得了重大进展，今天包括几种商业化的干细胞疗法。研究人员在干细胞疗法方面取得了显着的技术发展，以克服与大规模制造和细胞质量相关的挑战。干细胞研究更关注诱导多能干细胞，而不是间充质干细胞和造血干细胞，这是iPSC研究快速发展引起的转变。

Developments in technology platform help improve overall stem cell therapy and selection and reduce overall costs. Emerging companies are establishing newer cell isolation, characterization, and screening processes to ensure constant cell viability and maintenance..

技术平台的发展有助于改善整体干细胞治疗和选择，并降低总体成本。新兴公司正在建立更新的细胞分离，表征和筛选过程，以确保恒定的细胞活力和维持。。

Industry players increasingly adopt artificial intelligence and machine learning technologies for stem cell imaging, real-time tracking, and entering new disease areas. Stem cell therapies have huge potential in treating oncology, neurological conditions, and cardiac conditions, apart from rare diseases.

行业参与者越来越多地采用人工智能和机器学习技术进行干细胞成像，实时跟踪和进入新的疾病领域。除了罕见疾病外，干细胞疗法在治疗肿瘤学，神经系统疾病和心脏疾病方面具有巨大潜力。

Private investments and collaborations continue to drive stem cell R&D and push the clinical trial pipelines across various diseases..

私人投资和合作继续推动干细胞研发，推动各种疾病的临床试验管道。。

Key Questions This Study Addresses:

本研究解决的关键问题：

What is the current landscape of stem cell therapy, and what are the overall trends?

干细胞治疗的现状是什么，总体趋势是什么？

What are the technology developments improving stem cell therapy R&D?

哪些技术发展促进了干细胞疗法的研发？

Which companies are adopting new technology platforms to scale stem cell therapy R&D?

哪些公司正在采用新技术平台来扩大干细胞疗法的研发规模？

What is the investment and partnership ecosystem in stem cell therapy development?

干细胞疗法开发中的投资和合作生态系统是什么？

Growth Opportunities

增长机会

Growth Opportunity 1: Integration of AI and Automation to Improve Stem Cell Scalability

增长机会1：集成AI和自动化以提高干细胞的可扩展性

Growth Opportunity 2: Cell Engineering and Reprogramming Methods to Improve Stem Cell Quality

生长机会2：改善干细胞质量的细胞工程和重编程方法

Growth Opportunity 3: Focus on Cancer First and then on Rare Diseases

增长机会3：首先关注癌症，然后关注罕见疾病

Key Topics Covered:

涵盖的关键主题：

Strategic Imperatives

战略要务

Why Is It Increasingly Difficult to Grow?

为什么增长越来越困难？

The Strategic Imperative

战略要务

The Impact of the Top 3 Strategic Imperatives on the Cell and Gene Therapy Industry

前三大战略要务对细胞和基因治疗行业的影响

Growth Opportunities Fuel the Growth Pipeline Engine

增长机会推动增长管道引擎

Research Methodology

研究方法论

Growth Opportunity Analysis

Scope of Analysis

分析范围

Segmentation

细分

Growth Drivers

增长驱动因素

Growth Restraints

增长限制

Types of Common Stem Cells in Regenerative Medicine

再生医学中常见干细胞的类型

Overall Trends in Stem Cell Therapy Development

干细胞疗法发展的总体趋势

Snapshot of the Regenerative Medicine Landscape

再生医学景观快照

Growth Generator

生长发生器

Ongoing Challenges in the Development of Stem Cell Therapy

干细胞疗法发展中的持续挑战

Highly Adopted Stem Cells in Clinical Use to Develop Regenerative Medicine

临床上高度采用干细胞开发再生医学

Developments in iPSC Therapies

iPSC疗法的发展

Developments in MSCs

MSCs的发展

Developments in HSCs

Developments in hESC Therapies

hESC疗法的发展

Overall Technology Adoption by Stem Cell Therapy Developers

干细胞疗法开发人员采用的总体技术

Cell Manufacturing Platforms Enabling Stem Cell Development

支持干细胞发育的细胞制造平台

Stem Cell Selection and Characterization Platform

干细胞选择和表征平台

AI-integrated Platforms for Stem Cell Therapy Developments

用于干细胞治疗开发的AI集成平台

AI Platforms for Stem Cell Therapy Development

用于干细胞疗法开发的AI平台

Impact of Stem Cell Therapies in Various Diseases Areas

干细胞疗法在各种疾病领域的影响

Stem Cell Research, Private and Public Investment Landscape

干细胞研究，私人和公共投资前景

Public Investment Trends Driving Stem Cell Therapy Research

推动干细胞治疗研究的公共投资趋势

Recent Private Investments Driving Stem Cell Therapy Research

近期私人投资推动干细胞治疗研究

Growing M&As in Stem Cell Therapy

干细胞治疗中不断增长的并购

Growing Partnerships

不断增长的伙伴关系

Appendix

附录

Technology Readiness Level (TRL): Explanations

技术准备水平（TRL）：说明

Benefits and Impacts of Growth Opportunities

增长机会的好处和影响

For more information about this report visit https://www.researchandmarkets.com/r/zeu3lp

https://www.researchandmarkets.com/r/zeu3lp

About ResearchAndMarkets.com

关于ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com是全球领先的国际市场研究报告和市场数据来源。我们为您提供有关国际和地区市场、关键行业、顶尖公司、新产品和最新趋势的最新数据。